Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.
Horcajada JP, Sorlí L, Luque S, Benito N, Segura C, Campillo N, Montero M, Esteve E, Mirelis B, Pomar V, Cuquet J, Martí C, Garro P, Grau S. Horcajada JP, et al. Among authors: campillo n. Int J Antimicrob Agents. 2016 Dec;48(6):725-727. doi: 10.1016/j.ijantimicag.2016.08.020. Epub 2016 Oct 7. Int J Antimicrob Agents. 2016. PMID: 28128096
Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.
Montero MM, Domene Ochoa S, López-Causapé C, VanScoy B, Luque S, Sorlí L, Campillo N, Padilla E, Prim N, Segura C, Pomar V, Rivera A, Grau S, Ambrose PG, Oliver A, Horcajada JP. Montero MM, et al. Among authors: campillo n. J Glob Antimicrob Resist. 2019 Sep;18:37-44. doi: 10.1016/j.jgar.2019.04.012. Epub 2019 May 30. J Glob Antimicrob Resist. 2019. PMID: 31154007
Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.
Benítez-Cano A, de Antonio-Cuscó M, Luque S, Sorlí L, Carazo J, Ramos I, Bermejo S, Campillo N, Horcajada JP, Samsó E, Grau S. Benítez-Cano A, et al. Among authors: campillo n. J Antimicrob Chemother. 2019 Nov 1;74(11):3268-3273. doi: 10.1093/jac/dkz356. J Antimicrob Chemother. 2019. PMID: 31495877
Linezolid Dosing in Patients With Liver Cirrhosis: Standard Dosing Risk Toxicity.
Luque S, Muñoz-Bermudez R, Echeverría-Esnal D, Sorli L, Campillo N, Martínez-Casanova J, González-Colominas E, Álvarez-Lerma F, Horcajada JP, Grau S, Roberts JA. Luque S, et al. Among authors: campillo n. Ther Drug Monit. 2019 Dec;41(6):732-739. doi: 10.1097/FTD.0000000000000665. Ther Drug Monit. 2019. PMID: 31259884
Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model.
Montero M, Domene Ochoa S, López-Causapé C, VanScoy B, Luque S, Sorlí L, Campillo N, Angulo-Brunet A, Padilla E, Prim N, Pomar V, Rivera A, Grau S, Ambrose PG, Oliver A, Horcajada JP. Montero M, et al. Among authors: campillo n. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02542-19. doi: 10.1128/AAC.02542-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32041712 Free PMC article.
256 results